Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Cannabidiol on the Neural Glyoxalase Pathway Function and Longevity of Several C. elegans Strains Including a C. elegans Alzheimer’s Disease Model
Joel Frandsen, Prabagaran Narayanasamy
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 8, pp. 1165-1177
Closed Access | Times Cited: 10

Showing 10 citing articles:

Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer’s Disease
Jordan P. Hickey, Andrila E. Collins, Mackayla L. Nelson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4379-4402
Open Access | Times Cited: 9
Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications
Srushti Tambe, Suraj N. Mali, Purnima Amin, et al.
Journal of Integrative Medicine (2023) Vol. 21, Iss. 3, pp. 236-244
Closed Access | Times Cited: 17
Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis
Rahul Patil, Rashmi S. Tupe
Medicinal Research Reviews (2023) Vol. 44, Iss. 1, pp. 365-405
Closed Access | Times Cited: 12
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans
Zhizhen Wang, Jonathon C. Arnold
GeroScience (2024) Vol. 46, Iss. 6, pp. 5643-5661
Closed Access | Times Cited: 2
Alzheimer’s disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging
Liu Yan-ying
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Rhodium-Catalyzed Asymmetric Addition to 4- or 5-Carbonyl-cycloenones through Dynamic Kinetic Resolution: Enantioselective Synthesis of (−)-Cannabidiol
Wencong Li, He Meng, Jialin Ming, et al.
Organic Letters (2024) Vol. 26, Iss. 7, pp. 1364-1369
Closed Access | Times Cited: 1
C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties
Monique van Es‐Remers, Jesus Arellano Spadaro, Eefje S. Poppelaars, et al.
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 3
A systematic study of molecular targets of cannabidiol in Alzheimer's disease
Nil Patil, Kalpana S. Patil, Mukul Jain, et al.
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 1339-1360
Open Access
Cannabidiol and Trazodone Ameliorate Neuronal Proteotoxicity in C. elegans
Vincenzo S. Gilberto, Stephanie McGrath, Abdullatif M Alsulami, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top